Adelene Q Perkins Infinity Pharmaceuticals, Inc. (INFI) insider trading activity

INFI Quotes by TradingView

Adelene Q Perkins is Director of INFINITY PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.18 Million shares of INFI, which is worth approximately $0. The most recent transaction as insider was on Sep 12, 2023, when has been sold 410,196 shares (Common Stock) at a price of $0.07 per share, resulting in proceeds of $28,713. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.18M
0% 3M change
0% 12M change
Total Value Held $0

Adelene Q Perkins Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 12 2023
SELL
Open market or private sale
$28,713 $0.07 p/Share
410,196 Reduced 25.87%
1,175,291 Common Stock
Sep 09 2023
BUY
Exercise of conversion of derivative security
-
768,133 Added 32.64%
1,585,487 Common Stock

Also insider at

BRKR
BRUKER CORP Healthcare
AQP

Adelene Q Perkins

Director
Wayland, MA

Track Institutional and Insider Activities on INFI

Follow INFINITY PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INFI shares.

Notify only if

Insider Trading

Get notified when an Infinity Pharmaceuticals, Inc. insider buys or sells INFI shares.

Notify only if

News

Receive news related to INFINITY PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INFI